Preferences for different methods of communicating information regarding adjuvant chemotherapy for breast cancer

Studts, Jamie L.; Abell, Troy D.; Roetzer, Lynne M.; Albers, Ashley; McMasters, Kelly M.; Chao, Celia

doi:10.1002/pon.886

Cited by 16 publications

(22 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition to the potential importance of individualized tumor information, others have suggested that the ways recurrence and survival risks are presented may also impact receipt of chemotherapy. [11][12][13] Our findings support the need for further study of how knowledge about one's own disease specifically affects care and outcomes, with inclusion of factors such as information/learning preferences, detailed assessment of health literacy, social supports and whether they were present during discussions, and understanding other potential barriers to care. Certainly, improving knowledge about one's tumor characteristics is a modifiable factor that could be addressed in intervention studies.…”

Section: Discussionsupporting

confidence: 63%

“…[1][2][3][4][5] Studies patients with breast cancer has focused on understanding treatment options, general treatment rationales, and overall treatment benefits or how strategies in communicating recurrence information may affect treatment choices. [5][6][7][8][9][10][11][12][13] One study suggested that women who were under-treated for breast cancer were less likely than treated women to know that breast cancer treatments (ie, hormonal therapy and chemotherapy) improved survival. 8 However, past studies examining cancer knowledge have not focused on how knowing one's own cancer characteristics may affect treatment receipt.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment

Freedman

Kouri

West

et al. 2016

JOP

View full text Add to dashboard Cite

QUESTION ASKED: Is knowledge about one's cancer associated with treatment receipt for women with breast cancer?SUMMARY ANSWER: Knowledge about one's tumor characteristics was strongly associated with receipt of guideline-recommended therapies, suggesting the potential importance of knowledge about one's disease. METHODS:We surveyed women with stage I-III breast cancer diagnosed during 2010-2011. We assessed if reporting correct information about one's tumor, including stage, grade, estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status, was associated with guideline-recommended chemotherapy, radiation, and hormonal therapy using the California Cancer Registry for confirmation of tumor information. RESULTS (OR WHAT WE FOUND):Among 414 women eligible for adjuvant therapies, patients who reported correct stage and HER2 status were more likely to receive chemotherapy than those reporting incorrect information. Those correctly reporting ER status were more likely than others to receive hormonal therapy and those reporting correct stage were also more likely to receive radiation (Fig). BIAS, CONFOUNDING FACTOR(S), DRAWBACKS: Although our observations are provocative, our results are limited by a lack of detailed information on treatment discussions, information on trastuzumab receipt, treatment adherence, patient preferences, and if/how information was conveyed to patients. Our definitions for correct information also relied on the accuracy of registry data. Finally, although knowledge about one's tumor was associated with receipt of therapy, whether a woman received treatment as a result of that knowledge or knew her tumor characteristics because she received treatment is uncertain. REAL-LIFE IMPLICATIONS:Our findings underscore the major knowledge deficits women had about their own cancers and suggest that this knowledge may be important in receipt of guidelinerecommended treatments. Our observations highlight the need for further study of the clinical, emotional, and social consequences of poor knowledge and how we can improve information delivery to patients. Interventions to improve patients' knowledge and understanding of their cancers should be tested as a strategy for improving cancer care. Abstract PurposeKnowledge about one's breast cancer characteristics is poor, but whether this knowledge affects treatment is uncertain. Among women with breast cancer, we examined whether tumor knowledge was associated with adjuvant treatment receipt. MethodsWe surveyed a population-based sample of women in Northern California with stage 0 to III breast cancer diagnosed during 2010 to 2011 (participation rate, 68.5%). Interviews were conducted between 4 months and 3 years after diagnosis. Among 414 respondents with stage I to III disease, we examined receipt of guideline-recommended chemotherapy, radiation, and hormonal therapy by reporting correct information about one's tumor, including stage, estrogen receptor, human epidermal growth factor receptor 2 (HER2), and grade (using registry data fo...

show abstract

Section: Discussionsupporting

confidence: 63%

Section: Introductionmentioning

confidence: 99%

Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment

Freedman

Kouri

West

et al. 2016

JOP

View full text Add to dashboard Cite

show abstract

“…(39,43,44,46,47) The NNT describes the average number of people that should be treated to cure one person. Benefit information was presented, for example, as the absolute survival benefit (ASB) (39,44) or the personal probability of benefit (PPB). (43) These studies have already been discussed in the previous section; we therefore only mention the results related to NNT and benefit information.…”

Section: Number Needed To Treat and Benefit Informationmentioning

confidence: 99%

Probability Information in Risk Communication: A Review of the Research Literature

et al. 2009

View full text Add to dashboard Cite

Communicating probability information about risks to the public is more difficult than might be expected. Many studies have examined this subject, so that their resulting recommendations are scattered over various publications, diverse research fields, and are about different presentation formats. An integration of empirical findings in one review would be useful therefore to describe the evidence base for communication about probability information and to present the recommendations that can be made so far. We categorized the studies in the following presentation formats: frequencies, percentages, base rates and proportions, absolute and relative risk reduction, cumulative probabilities, verbal probability information, numerical versus verbal probability information, graphs, and risk ladders. We suggest several recommendations for these formats. Based on the results of our review, we show that the effects of presentation format depend not only on the type of format, but also on the context in which the format is used. We therefore argue that the presentation format has the strongest effect when the receiver processes probability information heuristically instead of systematically. We conclude that future research and risk communication practitioners should not only concentrate on the presentation format of the probability information but also on the situation in which this message is presented, as this may predict how people process the information and how this may influence their interpretation of the risk.

show abstract

“…Por outro lado, as razões vulgarmente alegadas pelos partidários de não oferecer informação aos doentes oncológicos centram-se, quase exclusivamente, nas possíveis consequências negativas que poderiam advir da prestação de informação, tais como a apreensão, ira e ansiedade (4,9) outros estudos mostram que dar informações aos doentes tem consequências positivas inclusivamente redutoras e esbatedoras da ansiedade (6,10) , favorecendo uma melhor adaptação psicossocial do doente (10) . Reforça-se, pois, a ideia de que a informação não é um fenómeno de tudo-ou-nada e que, para além disso, o médico não é a única fonte de informação a que o doente recorre, sem que, no entanto, pareça ter perdido o estatuto de fonte privilegiada.…”

Section: A Cronicidade Da Doença Oncológicaunclassified

O percurso do "doente oncológico": a (re)conceptualização do acto informativo

Laranjeira

2007

Rev. Bras. Enferm.

View full text Add to dashboard Cite

711Rev Bras Enferm, Brasília 2007 nov-dez; 60(6): 711-5.O percurso do "doente oncológico": a (re)conceptualização do acto informativo RESUMO A adaptação do doente às condições de cronicidade configura a informação prestada ao doente como uma das estratégias mais poderosas, susceptível de contribuir para a mudança da representação social do doente, de mero caso clínico à condição de ser holístico. O objectivo deste estudo foi investigar a produção científica em periódicos indexados nas bases de dados Medline, Lilacs, sobre o acto informativo e as modalidades de que se reveste a informação prestada ao doente oncológico, no período de 1990-2006. A análise da literatura, permite constatar um incremento nas publicações, sublinhando o papel do doente oncológico enquanto potenciador da emergência de estratégias de ajustamento psicossocial revelando o seu protagonismo no estatuto de "doente profissional". Descritores: Processo saúde-doença; Revelação; Consentimento esclarecido. ABSTRACT The adaptation of the patient to the conditions of chronic illness makes the information given to the patient one of the most powerful strategies, capable of contributing to a change in the social representation of the patient, from that of a mere clinical case to that of a holistic being. The objective of this study was to investigate the scientific work published in periodicals indexed by the Medline and Lilacs databases between 1990 and 2006 as to the informative act and the different forms in which information INTRODUÇÃOO médico, quando se engrandece de ciência, adquire uma utensilagem de saber que deverá utilizar na sua prática perante o doente. Porém a austeridade, a exactidão e a objectividade científicas deverão saber flexibilizar as suas fronteiras quando confrontadas com a pessoa doente. Só assim se permitirá à ciência médica a necessária agitação adaptativa quando se exerce em cada doente, contextualizado na sua realidade psicossocial, sem jamais se arriscar o carácter personalizado do diálogo terapêutico (1) . Todavia, a prática médica tem vindo a negligenciar o aspecto relacional, em explícito contraste com a intimidade que dantes emergia singelamente da permuta indulgente e afectiva entre médico e doente. Apela-se ao reequilíbrio entre as esferas técnico-científica e assistencial, recuperando a dimensão humanista (1) . O propósito essencial da medicina é o de restaurar a autonomia/independência à pessoa doente (2) . Conquanto, para que tal se torne possível no contexto da medicina actual, o doente terá que ser escutado

show abstract

Preferences for different methods of communicating information regarding adjuvant chemotherapy for breast cancer

Cited by 16 publications

References 36 publications

Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment

Association of Breast Cancer Knowledge With Receipt of Guideline-Recommended Breast Cancer Treatment

Probability Information in Risk Communication: A Review of the Research Literature

O percurso do "doente oncológico": a (re)conceptualização do acto informativo

Contact Info

Product

Resources

About